Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
ePOS Hybrid has developed a fully connected ePOS platform dedicated to the hospitality food industry. The company is on a mission to empower hospitality businesses to harness technology to improve the business operations, customer experience and profitability. Till now, they have secured an enterprise customer with locations throughout the UK and, in just 8 months, scaled from 0 to 200 customers, processing more than 400k orders. With the proceeds, the company plans to accelerate growth by increasing its market awareness and boosting sales.
days to go:
Expired
investment:
£363,830
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£326,190
Doodle Drinks (DD) aims to make all-natural soft drinks that kids can enjoy. The company cites research data arguing that children aged 18 months to 18 years are drinking 26% fewer sugary drinks and consumption for 10-year olds has fallen 35%. It wants to capture this sentiment and deliver a soft drink that's a healthy choice for both parents and their kids. DD has secured distribution with the noted distributor, Bravura Foods. It has also signed a partnership with the largest independent bottler of beverages in Europe and North America, Refresco, who have over 60 manufacturing sites globally to fulfil its objective. DD will use the investment to grow its business, execute its marketing strategy and increase its product range.
days to go:
Expired
investment:
£877,830
Drop Drinks creates vintage beverages with a distinctive taste. Theses beverages are inspired by traditional British sweets like Pear Drop and Cherry Drop. The company has sold more than 10,000 units since its launch in 2018. With more than 9,000 followers on social platforms such as Facebook and Instagram, Drop Drinks aims at increasing its product range to become a popular and leading drink brand domestically and grow globally. The company is now raising funds to increase production, execute an extensive go-to-market strategy, and hire key staff.
days to go:
Expired
investment:
£127,690
Peckwater Brands (PB) is a company engaged in the growing cloud kitchen/delivery business that runs virtual restaurant brands from the kitchens of existing restaurants. It argues that restaurants need to pay high street rents and staff wages no matter how many diners visit. Nearly 5,000 restaurants have closed in the UK since 2015 due to not being able to fulfil these tasks. PB aims to change this scenario. It helps restaurant partners use their existing staff and kitchen capacity better, and help keep struggling businesses running. The company received more than 10,000 customer orders through Deliveroo and Uber Eats. It witnessed more than £250,000 in customer sales since June 2020 and is spread across London, Manchester, Leeds, and Coventry. PB has launched four brands with four more in the pipeline. It will use the investment to get more partners, launch more brands, and acquire more customers.
days to go:
Expired
investment:
£232,208
Roqberry is a high-quality blended speciality tea made for millennial foodies. The company has received 20 Great Taste Awards and has secured listings with high-end distributors. It is stocked in speciality restaurants and retailers. Roqberry has been named as one of The Independent's "Best Plastic-Free Teabags". Already selling its products via its online shop and Amazon, the company is in discussion with other F&B chains, retailers and a major hotel. Roqberry is looking forward to scaling its B2B sales and B2C by hiring an account manager and new ops.
days to go:
Expired
investment:
£152,290
Big Night is an online food delivery service that partners with selected independent food vendors to deliver exceptional meals to customers at home, in their office or wherever they choose. The company asserts that 61% of non-millennials find delivery overall frustrating. Big Night aims to change this scenario. It has signed on ten notable restaurants and has ten more in the immediate pipeline. Onboarded restaurants include Two Lights, Luca, The Laughing Heart, Sager + Wilde, Royale, Levan, AngloThai, Legare and Mangal2. Over 4,000 people have ordered via Big Night since its launch. The company will use 25% of the investment for operations, 25% for marketing, and 50% to improve the Big Night platform.
days to go:
Expired
investment:
£274,168
Greenwall Environmental Group is a company engaged in making devices that can minimise non-biodegradable waste. It argues that asbestos remains the largest occupational killer in the UK today. Its product, Asbestosprobe, aims to change this situation. The company asserts that Asbestoprobe is arguably the world's first handheld analyser specifically designed to detect asbestos in real-time. It argues that current methods of detecting and recording the presence of asbestos are costly, invasive and slow. Asbestoprobe uses a point-and-click approach utilising NIR Spectroscopy and Artificial Intelligence (AI) to analyse the presence of asbestos in two minutes via the Asbestoprobe App. Greenwall plans to provide an annual software licensing model which grows through recurring revenue year on year. It endeavours to be a segment leader in the projected $1 billion global asbestos management market. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£253,017
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
